s6y
Company name or ticker
Search
Trevi Therapeutics, Inc.
8-K
Material agreement; Unregistered share sale
Filed
Monday, June 21, 2021
Period
Jun 18, 2021
Accession number
0001193125-21-195073
Documents
Current report filing
8-K
99.1
Press release or other material
EX-99.1
99.2
Press release or other material
EX-99.2
On sec.gov
Filing index
All files
Complete submission text
SGML header